Spinal Tumor Clinical Trials
The following trials for the treatment of various spinal cancer conditions are available for your participation. Click on the study number to view details of eligibility criteria.
Last updated 7/25/12
2008-0527: Surgical Versus Nonoperative Treatment of Metastatic Epidural Spinal Cord Compression (MESCC). Quality of Life and Cost-Effectiveness Outcomes.
Principal Investigator: Laurence Rhines, M.D.
The goal of this research study is to compare how patients recover from surgical and nonsurgical treatment for MESCC. Researchers want to study participants' quality of life and pain levels throughout their treatment and recovery. The cost effectiveness of surgical vs. nonsurgical treatments will also be compared.
CERN09-02: Phase II trial of carboplatin and bevacizumab for the treatment of recurrent low-grade and anaplastic supratentorial, infratentorial and spinal cord ependymoma in adults
Principal Investigator: Mark R. Gilbert, M.D.
The goal of this clinical research study is to learn if the combination of bevacizumab and carboplatin can help to control recurrent ependymoma. The safety of this drug combination will also be studied.
CERN08-02: A Phase II Study of Dose-Dense Temozolomide and Lapatinib for Recurrent Low-Grade and Anaplastic Supratentorial, Infratentorial and Spinal Cord Ependymoma
Principal Investigator: Mark R. Gilbert, M.D
The goal of this clinical researst study is to learn if lapatinib when given in combination with temozolomide can help to control ependymoma that has come back after treatment. The safety of this combination will also be studied.